Global Insomnia Epidemiology and Patient Flow Analysis - 2012

Fore Pharma, October 2012, Pages: 24

Fore Pharma announced the results of its Insomnia patient population study in a new report ‘Global Insomnia Epidemiology and Patient Flow Analysis - 2012’. The report provides insights into Insomnia epidemiology, Insomnia diagnosed patients, and Insomnia treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Insomnia derived from epidemiological analysis, percentage of patients diagnosed with Insomnia, and percentage of patients treated with Insomnia therapy.

The study helps executives estimate Insomnia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Insomnia prevalence, Insomnia diagnosis rate, and Insomnia treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:
- Insomnia: Disease Definition
- Insomnia Patient Flow
- Insomnia Prevalence
- Insomnia Diagnosed Patients
- Insomnia Treated Patients

1. Insomnia: Disease Definition
2. Global Insomnia Patient Flow
2A. Global Insomnia Prevalence
2B. Global Insomnia Diagnosed Patients
2C. Global Insomnia Treated Patients
3. Insomnia Patient Flow in the US
3A. Insomnia Prevalence in the US
3B. Insomnia Diagnosed Patients in the US
3C. Insomnia Treated Patients in the US
4. Insomnia Patient Flow in Europe
4A. Insomnia Prevalence in Europe
4B. Insomnia Diagnosed Patients in Europe
4C. Insomnia Treated Patients in Europe
5. Insomnia Patient Flow in Germany
5A. Insomnia Prevalence in Germany
5B. Insomnia Diagnosed Patients in Germany
5C. Insomnia Treated Patients in Germany
6. Insomnia Patient Flow in France
6A. Insomnia Prevalence in France
6B. Insomnia Diagnosed Patients in France
6C. Insomnia Treated Patients in France
7. Insomnia Patient Flow in Spain
7A. Insomnia Prevalence in Spain
7B. Insomnia Diagnosed Patients in Spain
7C. Insomnia Treated Patients in Spain
8. Insomnia Patient Flow in Italy
8A. Insomnia Prevalence in Italy
8B. Insomnia Diagnosed Patients in Italy
8C. Insomnia Treated Patients in Italy
9. Insomnia Patient Flow in UK
9A. Insomnia Prevalence in UK
9B. Insomnia Diagnosed Patients in UK
9C. Insomnia Treated Patients in UK
10. Insomnia Patient Flow in Japan
10A. Insomnia Prevalence in Japan
10B. Insomnia Diagnosed Patients in Japan
10C. Insomnia Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources

Table 1: Global Insomnia Patient Flow (2012)
Table 2: Global Insomnia Patient Flow Forecast (2012-2019)
Table 3: Insomnia Patient Flow in the US (2012)
Table 4: Insomnia Patient Flow Forecast in the US (2012-2019)
Table 5: Insomnia Patient Flow in Europe (2012)
Table 6: Insomnia Patient Flow Forecast in Europe (2012-2019)
Table 7: Insomnia Patient Flow in Germany (2012)
Table 8: Insomnia Patient Flow Forecast in Germany (2012-2019)
Table 9: Insomnia Patient Flow in France (2012)
Table 10: Insomnia Patient Flow Forecast in France (2012-2019)
Table 11: Insomnia Patient Flow in Spain (2012)
Table 12: Insomnia Patient Flow Forecast in Spain (2012-2019)
Table 13: Insomnia Patient Flow in Italy (2012)
Table 14: Insomnia Patient Flow Forecast in Italy (2012-2019)
Table 15: Insomnia Patient Flow in UK (2012)
Table 16: Insomnia Patient Flow Forecast in UK (2012-2019)
Table 17: Insomnia Patient Flow in Japan (2012)
Table 18: Insomnia Patient Flow Forecast in Japan (2012-2019)

Figure 1: Global Insomnia Patient Flow (2012)
Figure 2: Global Insomnia Patient Flow Forecast (2012-2019)
Figure 3: Insomnia Patient Flow in the US (2012)
Figure 4: Insomnia Patient Flow Forecast in the US (2012-2019)
Figure 5: Insomnia Patient Flow in Europe (2012)
Figure 6: Insomnia Patient Flow Forecast in Europe (2012-2019)
Figure 7: Insomnia Patient Flow in Germany (2012)
Figure 8: Insomnia Patient Flow Forecast in Germany (2012-2019)
Figure 9: Insomnia Patient Flow in France (2012)
Figure 10: Insomnia Patient Flow Forecast in France (2012-2019)
Figure 11: Insomnia Patient Flow in Spain (2012)
Figure 12: Insomnia Patient Flow Forecast in Spain (2012-2019)
Figure 13: Insomnia Patient Flow in Italy (2012)
Figure 14: Insomnia Patient Flow Forecast in Italy (2012-2019)
Figure 15: Insomnia Patient Flow in UK (2012)
Figure 16: Insomnia Patient Flow Forecast in UK (2012-2019)
Figure 17: Insomnia Patient Flow in Japan (2012)
Figure 18: Insomnia Patient Flow Forecast in Japan (2012-2019)

Customers who bought this item also bought

• Global Insomnia Drug Pipeline Capsule - 2012
• Epidemiology: Insomnia
• Medical Nutrition - A Global Market Overview
• Disinfectants - Global Strategic Business Report
• Wheelchairs (Powered and Manual) - Global Strategic Business Report
• Minimally Invasive BPH and Prostate Cancer Treatment Devices Markets Worldwide
• Monolithic Ceramics Applications - A Global Market Overview
• Medical Ceramics - Global Market Overview
• Patient Monitors: Equipment & Accessories – A Global Market Overview
• Anesthesia Disposables - Global Strategic Business Report